Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983;42(4):391-8.

[Effect of central effective substances on alcohol preference]

[Article in German]
  • PMID: 6138034

[Effect of central effective substances on alcohol preference]

[Article in German]
K Andreas et al. Biomed Biochim Acta. 1983.

Abstract

The alcohol preference has been used as a model of drug habituation in animal experiments in order to examine the influence of altered synaptic efficiency of central transmission systems following acute receptor reactions with agonists or antagonists as well as by alterations of receptor sensitivity in mice. Ethanol in 10 per cent solution as the only beverage over 4 weeks produces an ethanol preference quotient 1 in the free choice of ethanol solution and water. Control animals without ethanol exposure before the preference test are only drinking water and refuse ethanol. A single injection of haloperidol increases the preference, apomorphine as well as a long term haloperidol administration producing a dopaminergic supersensitivity diminishes the preference. Moreover the preference is enhanced by atropine, isoprenaline and pholedrine and is decreased by arecoline, propranolol and phenoxybenzamine. Cyproheptadine and picrotoxine do not influence the preference. The results point to a preference promoting influence of the alpha- and beta-adrenergic transmission and to an inhibition by dopaminergic and cholinergic activity. An influence by the 5-HT and GABA system could not be observed. Additionally the paper describes the decrease of the ethanol preference by the nootropics piracetam, meclofenoxane, methylglucamine orotate and nicergoline.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources